Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Nihon Chouzai Co ( (JP:3341) ) is now available.
Nihon Chouzai Co., Ltd. has announced the setting of a record date for voting rights in anticipation of an extraordinary general meeting of shareholders, potentially scheduled for mid-November 2025. This meeting is contingent on the outcomes of a tender offer by AP86 Co., Ltd. for the company’s shares. If the tender offer is successful but does not result in the acquisition of all shares, the meeting will address proposals for share consolidation and amendments to the articles of incorporation. The meeting will not occur if the tender offer either fails or results in the acquisition of all targeted shares.
The most recent analyst rating on (JP:3341) stock is a Hold with a Yen3834.00 price target. To see the full list of analyst forecasts on Nihon Chouzai Co stock, see the JP:3341 Stock Forecast page.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the healthcare industry, focusing on pharmaceutical services and products. The company is listed on the Tokyo Stock Exchange Prime Market under the securities code 3341.
Average Trading Volume: 257,774
Technical Sentiment Signal: Buy
Current Market Cap: Yen113.5B
For detailed information about 3341 stock, go to TipRanks’ Stock Analysis page.